A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer
Clinical trial NCT05859750 · RECRUITING
Trial details
- NCT number
- NCT05859750
- Sponsor
- Akeso
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-25
- Primary completion
- 2025-06-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.